Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.


Lantern Residents Celebrate "Make A Difference In Children" Week

The Lantern at Morning Pointe Alzheimer's Center of Excellence, Collegedale celebrated "Make a Difference in Children Week," inviting local home-schooled children and their own great-grandchildren to create their very own lollipops.   The children even got a surprise science lesson as they witnessed a cool dry ice exhibit.   As part of the Meaningful Day program, ... (click for more)

Morning Pointe Residents Create Floral Arrangements For Salvation Army

Morning Pointe of Chattanooga at Shallowford residents created dozens of beautiful floral arrangements on the Chattanooga Salvation Army's "Flowers of Hope Day." As part of the Life Enrichment Program, the assisted living community embraces acts of kindness through its partnerships with local nonprofit organizations, spreading goodwill to everyone they meet.  ... (click for more)

$30 Million Development Planned At King And South Market; Will Include Hotel, Condos, Offices, Retail, Possible Restaurant

A new $30 million development is planned for the Southside at King Street and South Market. Nick Wilkinson, city deputy director for economic development, said it will include a hotel, condos, offices, retail and possibly a restaurant. It could also include some light industry. A storage building and a parking lot are now at the site. He said the developers plan to reuse ... (click for more)

DA's Office Defends Suspended Sentence In School Bus Driver Rape Case

The District Attorney's Office defended a controversial suspended sentence in a rape case involving a substitute county school bus driver. Prosecutor Jason Demastus said the victim, who was 15 years old at the time of the March 2015 incident, was in agreement on the plea and refused to testify against Alexander Rodriquez. Rodriguez, 34, last Thursday pleaded guilty to ... (click for more)

Make America Good Again - And Response

“No people can be great, who have ceased to be virtuous.”   Samuel Johnson (1709 – 1784) Last week I witnessed first hand the 2016 Republican National Convention in Cleveland, Ohio. As I observed the happenings within the Quicken Arena, the one theme that continued to pop up again and again, was  Make America Great Again .  Of course, that being ... (click for more)

Roy Exum: Keep Mike Carter’s Genius

Mike Carter, who has just been chosen as the “Best Overall” member of the Tennessee Legislature by a group known as the Tennessee Forum and “Legislator of the Year” by Citizens for Home Rule, is truly both. A lawyer and then a Sessions Court judge for 8 ½ years, he is overwhelmingly favored to win a third term during next Thursday’s election and rightly so. While it is laudable ... (click for more)